Late leptomeningeal dissemination of a primary intramedullary spinal cord melanoma after three years of control on pembrolizumab.

Rahamimov O, Livoff A, Frommer-Shapira R, Rahamimov N

Open source

DOI
10.1136/bcr-2026-276693
Published
2026 Nov 9
Container
BMJ case reports
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bcr-2026-276693,
  title = {Late leptomeningeal dissemination of a primary intramedullary spinal cord melanoma after three years of control on pembrolizumab.},
  author = {Rahamimov O and Livoff A and Frommer-Shapira R and Rahamimov N},
  year = {2026},
  journal = {BMJ case reports},
  doi = {10.1136/bcr-2026-276693},
  url = {https://doi.org/10.1136/bcr-2026-276693}
}

RIS

TY  - JOUR
TI  - Late leptomeningeal dissemination of a primary intramedullary spinal cord melanoma after three years of control on pembrolizumab.
AU  - Rahamimov O
AU  - Livoff A
AU  - Frommer-Shapira R
AU  - Rahamimov N
PY  - 2026
JO  - BMJ case reports
DO  - 10.1136/bcr-2026-276693
UR  - https://doi.org/10.1136/bcr-2026-276693
ER  - 

APA

O, R., A, L., R, F., & N, R. (2026). Late leptomeningeal dissemination of a primary intramedullary spinal cord melanoma after three years of control on pembrolizumab.. BMJ case reports. https://doi.org/10.1136/bcr-2026-276693

Source records